Free Trial

Adicet Bio (ACET) Insider Trading & Ownership

Adicet Bio logo
$1.33 +0.03 (+2.31%)
(As of 11/7/2024 ET)

Adicet Bio (NASDAQ:ACET) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7.50 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$8,437.00
Get ACET Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adicet Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACET Insider Buying and Selling by Quarter

Adicet Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/5/2024Michael KauffmanDirectorSell5,900$1.43$8,437.00  
1/25/2024Orbimed Advisors LlcDirectorBuy3,125,000$2.40$7,500,000.00  
(Data available from 1/1/2013 forward)

ACET Insider Trading Activity - Frequently Asked Questions

The list of insiders at Adicet Bio includes Andrew Sinclair, Aya Jakobovits, Blake Aftab, Carl L Gordon, Chen Schor, Don Healey, Francesco Galimi, Michael Kauffman, Orbimed Advisors Llc, and Steve Dubin. Learn more on insiders at ACET.

19.10% of Adicet Bio stock is owned by insiders. Learn more on ACET's insider holdings.

The following insiders have purchased ACET shares in the last 24 months: Carl L Gordon ($1,828,750.00), Chen Schor ($15,125.00), Orbimed Advisors Llc ($7,500,000.00), and Steve Dubin ($12,000.00).

Insiders have purchased a total of 4,016,000 ACET shares in the last 24 months for a total of $9,355,875.00 bought.

The following insiders have sold ACET shares in the last 24 months: Blake Aftab ($146,307.00), Chen Schor ($209,353.65), Don Healey ($117,841.47), and Michael Kauffman ($8,437.00).

Insiders have sold a total of 37,822 Adicet Bio shares in the last 24 months for a total of $481,939.12 sold.

Adicet Bio Key Executives

  • Mr. Chen Schor BAMr. Chen Schor BA (Age 52)
    CPA, M.B.A., CEO, President & Director
    Compensation: $871.97k
  • Dr. Aya Jakobovits Ph.D. (Age 69)
    Founder & Independent Director
    Compensation: $45k
  • Mr. Brian Nicholas Harvey (Age 63)
    Chief Financial Officer
    Compensation: $594.94k
  • Dr. Donald Healey Ph.D. (Age 62)
    Chief Technology Officer
    Compensation: $606.34k
  • Dr. Blake Aftab Ph.D. (Age 43)
    Senior VP & Chief Scientific Officer
    Compensation: $675.04k
  • Ms. Amy Locke
    Chief Human Resource Officer
  • Dr. Francesco Galimi M.D. (Age 56)
    Ph.D., Chief Medical Officer & Senior VP
    Compensation: $680.37k
  • Dr. Nancy L. Boman M.D.
    Ph.D., Senior VP & Chief Regulatory Officer


This page (NASDAQ:ACET) was last updated on 11/7/2024 by MarketBeat.com Staff
From Our Partners